文献速递产科母胎医学

危险因素对阿司匹林预防早产疗效的影响

The impact of risk factors on aspirin's efficacy for the prevention of preterm birth.
PubMed 文献 · Am J Obstet Gynecol MFM · 2023-08-12

本研究为阿司匹林补充预防初产妇妊娠相关风险降低试验的非预设二次分析,纳入6个中低收入国家11558名初产妇。低剂量阿司匹林在有无额外子痫前期危险因素的初产妇中降低37周前早产风险相似(RR 0.75 vs 0.85,P=.35),但无额外危险因素者34周前早产降低更显著(RR 0.69 vs 1.04,P=.04)。

要点

  • 低剂量阿司匹林降低37周前早产风险在有无额外危险因素者中相似。
  • 无额外危险因素者34周前早产降低更显著(RR 0.69 vs 1.04,P=.04)。
  • 作者认为专业学会应考虑推荐所有初产妇使用低剂量阿司匹林。

核心结论

  • 低剂量阿司匹林预防早产、妊娠期高血压疾病和围产期死亡在有无额外危险因素的初产妇中效果相似。
  • 作者认为专业学会应考虑推荐所有初产妇使用低剂量阿司匹林。

研究设计与样本

  • 阿司匹林补充预防初产妇妊娠相关风险降低试验的非预设二次分析。
  • 随机纳入6个中低收入国家单胎妊娠初产妇,接受低剂量阿司匹林或安慰剂。
  • 主要暴露为除初产外存在额外子痫前期危险因素。
  • 主要结局为37周前早产,次要结局包括34周前早产、28周前早产、妊娠期高血压疾病和围产期死亡。
  • 共11558名初产妇符合纳入标准,其中66.8%无额外危险因素。

主要发现

  • 低剂量阿司匹林降低37周前早产风险在有无额外危险因素者中相似(相对风险:0.75 vs 0.85;P=.35)。
  • 低剂量阿司匹林降低28周前早产、妊娠期高血压疾病和围产期死亡风险在有无额外危险因素者中相似。
  • 低剂量阿司匹林降低34周前早产风险在无额外危险因素者中显著大于有额外危险因素者(相对风险:0.69 vs 1.04;P=.04)。

关键数值与推荐

  • 美国预防服务工作组指南推荐≥2个中度危险因素者使用低剂量阿司匹林。
  • 本研究纳入初产妇至少有1个中度危险因素(初产),随机接受低剂量阿司匹林 regardless of 额外危险因素存在与否。

临床怎么用

  • 作者认为专业学会应考虑推荐所有初产妇使用低剂量阿司匹林。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas trial was a landmark study that demonstrated a reduction in preterm birth and hypertensive disorders of pregnancy in nulliparous women who received low-dose aspirin. All women in the study had at least 1 moderate-risk factor for preeclampsia (nulliparity). Unlike current US Preventative Service Task Force guidelines, which recommend low-dose aspirin for ≥2 moderate-risk factors, women in this study were randomized to receive low-dose aspirin regardless of the presence or absence of an additional risk factor. OBJECTIVE: This study aimed to compare how low-dose aspirin differentially benefits nulliparous women with and without additional preeclampsia risk factors for the prevention of preterm birth and hypertensive disorders of pregnancy. STUDY DESIGN: This was a non-prespecified secondary analysis of the Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas trial that randomized nulliparous women with singleton pregnancies from 6 low-middle-income countries to receive low-dose aspirin or placebo. Our primary exposure was having an additional preeclampsia risk factor beyond nulliparity. Our primary outcome was preterm birth before 37 weeks of gestation, and our secondary outcomes included preterm birth before 34 weeks of gestation, preterm birth before 28 weeks of gestation, hypertensive disorders of pregnancy, and perinatal mortality. RESULTS: Among 11,558 nulliparous women who met the inclusion criteria, 66.8% had no additional risk factors. Low-dose aspirin similarly reduced the risk of preterm birth at <37 weeks of gestation in women with and without additional risk factors (relative risk: 0.75 vs 0.85; P=.35). Additionally for our secondary outcomes, low-dose aspirin similarly reduced the risk of preterm birth at <28 weeks of gestation, hypertensive disorders of pregnancy, and perinatal mortality in women with and without additional risk factors. The reduction of preterm birth at <34 weeks of gestation with low-dose aspirin was significantly greater in women without additional risk factors than those with an additional risk factor (relative risk: 0.69 vs 1.04; P=.04). CONCLUSION: Low-dose aspirin's ability to prevent preterm birth, hypertensive disorders of pregnancy, and perinatal mortality was similar in nulliparous women with and without additional risk factors. Professional societies should consider recommending low-dose aspirin to all nulliparous women.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Nuss EE, Hoffman MK, Goudar SS, et al. The impact of risk factors on aspirin's efficacy for the prevention of preterm birth. Am J Obstet Gynecol MFM. 2023. PMID: 37574046. doi:10.1016/j.ajogmf.2023.101095

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。